Non Small Cell Lung Cancer

Showing 26 - 50 of 769

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer Trial (LungCaNN)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • LungCaNN
  • (no location specified)
Jul 6, 2023

Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride

Recruiting
  • Non Small Cell Lung Cancer
  • TQB2450 injection + Chemotherapy
  • TQB2450 injection + Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +9 more
Jun 27, 2023

Circulating Tumor DNA After Stereotactic Ablative Radiotherapy

Recruiting
  • Non Small Cell Lung Cancer
    • London, Ontario, Canada
      London Health Sciences Centre
    Jun 19, 2023

    Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

    Recruiting
    • Non Small Cell Lung Cancer
    • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
    • Leiden, Zuid-Holland, Netherlands
    • +1 more
    Jun 1, 2023

    Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Fairfax, Virginia
      NEXT Oncology
    Jun 7, 2023

    Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

    Recruiting
    • Lung Cancer
    • +11 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Anqing, Anhui, China
      The PLA Navy Anqing Hospital
    May 23, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumor
    • +7 more
    • WM-A1-3389
    • Pembrolizumab
    • Seoul, Seocho-gu, Korea, Republic of
    • +1 more
    May 14, 2023

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

    Not yet recruiting
    • Melanoma
    • +16 more
    • Darlinghurst, New South Wales, Australia
    • +3 more
    May 12, 2023

    Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Guanzhou, China
      SunYat-senU
    May 5, 2023

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

    Recruiting
    • Invasive Ductal Breast Carcinoma
    • +14 more
    • Stereotactic body radiotherapy
    • Lattice Radiation Therapy
    • Basking Ridge, New Jersey
    • +6 more
    Apr 20, 2023

    Lung Cancer, Non Small Cell Lung Cancer Trial in Ankara (Low Volume High Intensity Exercise Training, Aerobic Exercise Training)

    Recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Low Volume High Intensity Exercise Training
    • Aerobic Exercise Training
    • Ankara, Sıhhiye, Turkey
      Ankara University
    Apr 27, 2023

    Radiomics for prEdiction of lunG cAncer biologY

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • PET/CT
    • Poitiers, France
      CHU Poitiers
    Apr 5, 2023

    Expressiona and Diagnostic Potential of miRNAs in NSCLC

    Completed
    • Non Small Cell Lung Cancer
    • No intervention
    • Cairo, Egypt
      Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
    Apr 4, 2023

    Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)

    Enrolling by invitation
    • Non Small Cell Lung Cancer
    • Furmonertinib Mesilate Tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Apr 3, 2023

    Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

    Not yet recruiting
    • Head and Neck Cancer
    • +8 more
    • Tumor and HLA Profiling
    • (no location specified)
    Mar 31, 2023

    Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Brain Metastases
    • (no location specified)
    Apr 2, 2023

    Non Small Cell Lung Cancer Trial in New York (Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation
    • New York, New York
    • +3 more
    Mar 31, 2023

    Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • increasing total fiber intake
    • Montréal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal (CHUM)
    Apr 6, 2023

    Results of Specific Gene Testing and Efficacy of Targeted

    Completed
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Mar 27, 2023

      Lung Cancer Multi-omics Digital Human Avatars for Integrating

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • surgical resection
      • (no location specified)
      Apr 4, 2023

      Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

      Recruiting
      • Lung Cancer
      • +2 more
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Mar 24, 2023

      Advanced Cancer, Non Small Cell Lung Cancer Trial (Tepotinib, Pembrolizumab)

      Not yet recruiting
      • Advanced Cancer
      • Non Small Cell Lung Cancer
      • (no location specified)
      Mar 28, 2023

      Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer Trial (HFB200603, Tislelizumab)

      Not yet recruiting
      • Renal Cell Carcinoma
      • +4 more
      • (no location specified)
      Mar 15, 2023